Our multidisciplinary program examines several aspects of how placental biology that can influence fetal physiology. This program includes the following key studies: evaluation of the effects of prenatal exposure to opioids on the placenta including DNA methylation and gene expression, examination of COVID-19 biology during pregnancy and analysis of how placental disorders impact development to increase the risk of neonatal lung and gut disorders.
See all of our Pediatric Research programs.
Contact
Principal Investigator
Elizabeth Taglauer
Elizabeth.Taglauer@bmc.org
Research projects
- “MOM NEST” Study: Safety, Efficacy, Pharmacokinetics, and Pharmacogenomics of Naltrexone in Pregnant Women with Opioid Use Disorder (R01 HD96798), NCT03718104
- Effects of Prenatal Opioid Exposure on Placental DNA Methylation and Gene Expression, March of Dimes Research Grant
- “MASC” Study: Mothers and Infants Affected by Signs and Symptoms of COVID-19, BU CTSI
- “AliGN” Study: Antenatal determinants of Lung and Gut disease in Neonates
- “PRIME” Study: Placental Repository to Improve Infant Outcomes